China Pharma Holdings, Inc.: Form 10-Q/A for the period ended Jun 30, 2011
Filed with the SEC on Sep 6, 2011 and accepted by EDGAR at Sep 6, 2011, 16:51 ET.
Sections
No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2011-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2011-04-01 to 2011-06-30 | $19.6m | us-gaap:Revenues |
| Revenue | 6 months2011-01-01 to 2011-06-30 | $37.7m | us-gaap:Revenues |
| Cost of revenue | 3 months2011-04-01 to 2011-06-30 | $12.3m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2011-01-01 to 2011-06-30 | $23.6m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2011-04-01 to 2011-06-30 | $7.3m | us-gaap:GrossProfit |
| Gross profit | 6 months2011-01-01 to 2011-06-30 | $14.2m | us-gaap:GrossProfit |
| Operating income | 3 months2011-04-01 to 2011-06-30 | $5.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2011-01-01 to 2011-06-30 | $11.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2011-04-01 to 2011-06-30 | −$61.2k | us-gaap:InterestExpense |
| Interest expense | 6 months2011-01-01 to 2011-06-30 | −$122.4k | us-gaap:InterestExpense |
| Income tax | 3 months2011-04-01 to 2011-06-30 | −$888.9k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2011-01-01 to 2011-06-30 | −$1.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2011-04-01 to 2011-06-30 | $5.1m | us-gaap:NetIncomeLoss |
| Net income | 6 months2011-01-01 to 2011-06-30 | $10.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2011-04-01 to 2011-06-30 | $0.12 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2011-01-01 to 2011-06-30 | $0.23 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2011-04-01 to 2011-06-30 | $0.12 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2011-01-01 to 2011-06-30 | $0.23 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 6 months2011-01-01 to 2011-06-30 | $3.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2011-01-01 to 2011-06-30 | −$223.8k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2011-06-30 | $4.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2011-06-30 | $101.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2011-06-30 | $143.4m | us-gaap:Assets |
| Current liabilities | At period end2011-06-30 | $12.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2011-06-30 | $12.4m | us-gaap:Liabilities |
| Shareholders' equity | At period end2011-06-30 | $131.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001010549-11-000997. Last ingested by Listed: Oct 30, 2026, 16:51 ET. Listed shows no prices and gives no investment advice.